York Michael Insider Trades

Insider Trading History

Track insider trading activity for York Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Metacrine
Metacrine MTCR
Chief Business Officer
Holding Value $60.2k 103,499 shares
Last Trade
Jan 26, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.7k 107,054 shares
$0.48
$0.58
Metacrine
Metacrine MTCR
Chief Business Officer
Holding Value $122k 210,553 shares
Last Trade
Feb 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$198k 421,106 shares
$0.47
$0.58
Metacrine
Metacrine MTCR
Chief Business Officer
Holding Value $0 0 shares
Last Trade
Feb 18, 2022 Sale
$105k 235,000 shares
$0.45
$0.58
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Vp, Corporate Development
Holding Value $495 7,059 shares
Last Trade
May 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.53k 2,897 shares
$3.29
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Vp, Corporate Development
Holding Value $2.52k 36,000 shares
Last Trade
Feb 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$155k 36,000 shares
$4.31
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Vp, Corporate Development
Holding Value $292 4,162 shares
Last Trade
Nov 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.4k 2,662 shares
$3.53
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Vp, Corporate Development
Holding Value $3.86k 55,000 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$285k 55,000 shares
$5.19
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Vp, Corporate Development
Holding Value $3.15k 45,000 shares
Last Trade
Feb 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 45,000 shares
$3.15
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Vp, Corporate Development
Holding Value $105 1,500 shares
Last Trade
Dec 11, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.82k 1,500 shares
$3.88
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Vp, Corporate Development
Holding Value $0 0 shares
Last Trade
Oct 17, 2018 Sale
No data
No data
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up